1986
DOI: 10.1007/bf02889977
|View full text |Cite
|
Sign up to set email alerts
|

Fatal mitochondrial cardiomyopathy in Kearns-Sayre syndrome with deficiency of cytochrome-c-oxidase in cardiac and skeletal muscle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

1989
1989
2022
2022

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(7 citation statements)
references
References 35 publications
0
7
0
Order By: Relevance
“…cardiomyopathy [105]. In some patients, the mitochondrial dysfunction is treatable by supplementation with vitamins, coenzyme Q and / or carnitine.…”
Section: Nuclear Mutations In Mitochondrial Componentsmentioning
confidence: 99%
“…cardiomyopathy [105]. In some patients, the mitochondrial dysfunction is treatable by supplementation with vitamins, coenzyme Q and / or carnitine.…”
Section: Nuclear Mutations In Mitochondrial Componentsmentioning
confidence: 99%
“…Specific defects of complex I [24,28], complex III [29], complex IV [7,21,39], complex III+ IV [6,20,30] and, most frequently, complex I + IV [33,34,40] have been described. There have also been reports of mitochondrial cardiomyopathy in Kearns-Sayre syndrome, with focal deficiency of cytochrome c oxidase in cardiac and skeletal muscle [25]; this presumably reflects the non-uniform distribution of normal and deleted mitochondrial DNA (mtDNA) in that disease [35]. Isolated cardiomyocytes deficient in cytochrome c oxidase were also observed in our patient, suggesting the possibility of a mitochondrially encoded defect [26].…”
Section: Discussionmentioning
confidence: 60%
“…These modifications induced by Cu lead to the regression of pathological cardiac hypertrophy. activity was observed in human hearts with cardiac hypertrophy (Muller-Hocker et al, 1986;Zeviani et al, 1986;Buchwald et al, 1990). A clinical study found that the nuclear encoded subunits of CCO were diminished in the pathologically hypertrophic hearts (Liebes & Medeiros, 1997).…”
Section: Depressed Cco Activity In Cardiac Hypertrophymentioning
confidence: 96%